Literature DB >> 28321318

Does the model of additive effect in placebo research still hold true? A narrative review.

Katja Boehm1, Bettina Berger2, Ulrich Weger3, Peter Heusser2.   

Abstract

Personalised and contextualised care has been turned into a major demand by people involved in healthcare suggesting to move toward person-centred medicine. The assessment of person-centred medicine can be most effectively achieved if treatments are investigated using 'with versus without' person-centredness or integrative study designs. However, this assumes that the components of an integrative or person-centred intervention have an additive relationship to produce the total effect. Beecher's model of additivity assumes an additive relation between placebo and drug effects and is thus presenting an arithmetic summation. So far, no review has been carried out assessing the validity of the additive model, which is to be questioned and more closely investigated in this review. Initial searches for primary studies were undertaken in July 2016 using Pubmed and Google Scholar. In order to find matching publications of similar magnitude for the comparison part of this review, corresponding matches for all included reviews were sought. A total of 22 reviews and 3 clinical and experimental studies fulfilled the inclusion criteria. The results pointed to the following factors actively questioning the additive model: interactions of various effects, trial design, conditioning, context effects and factors, neurobiological factors, mechanism of action, statistical factors, intervention-specific factors (alcohol, caffeine), side-effects and type of intervention. All but one of the closely assessed publications was questioning the additive model. A closer examination of study design is necessary. An attempt in a more systematic approach geared towards solutions could be a suggestion for future research in this field.

Entities:  

Keywords:  Placebo; additive effect; person-centred medicine; review

Year:  2017        PMID: 28321318      PMCID: PMC5347270          DOI: 10.1177/2054270416681434

Source DB:  PubMed          Journal:  JRSM Open        ISSN: 2054-2704


  71 in total

1.  Unbalanced randomization influences placebo response: scientific versus ethical issues around the use of placebo in migraine trials.

Authors:  H C Diener; A J Dowson; M Ferrari; G Nappi; P Tfelt-Hansen
Journal:  Cephalalgia       Date:  1999-10       Impact factor: 6.292

2.  The powerful placebo.

Authors:  H K BEECHER
Journal:  J Am Med Assoc       Date:  1955-12-24

3.  Drug-related information generates placebo and nocebo responses that modify the drug response.

Authors:  M A Flaten; T Simonsen; H Olsen
Journal:  Psychosom Med       Date:  1999 Mar-Apr       Impact factor: 4.312

Review 4.  Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.

Authors:  Mark Sinyor; Anthony J Levitt; Amy H Cheung; Ayal Schaffer; Alex Kiss; Yekta Dowlati; Krista L Lanctôt
Journal:  J Clin Psychiatry       Date:  2010-01-26       Impact factor: 4.384

5.  Introduction to placebo effects in medicine: mechanisms and clinical implications.

Authors:  Karin Meissner; Niko Kohls; Luana Colloca
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-06-27       Impact factor: 6.237

6.  Effects of expectation on placebo-induced dopamine release in Parkinson disease.

Authors:  Sarah C Lidstone; Michael Schulzer; Katherine Dinelle; Edwin Mak; Vesna Sossi; Thomas J Ruth; Raul de la Fuente-Fernández; Anthony G Phillips; A Jon Stoessl
Journal:  Arch Gen Psychiatry       Date:  2010-08

7.  The placebo effect revisited: lessons learned to date.

Authors:  Irving Kirsch
Journal:  Complement Ther Med       Date:  2013-01-05       Impact factor: 2.446

Review 8.  Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.

Authors:  George I Papakostas; Maurizio Fava
Journal:  Eur Neuropsychopharmacol       Date:  2008-09-26       Impact factor: 4.600

Review 9.  Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder.

Authors:  Jeffrey A Bridge; Boris Birmaher; Satish Iyengar; Rémy P Barbe; David A Brent
Journal:  Am J Psychiatry       Date:  2008-12-01       Impact factor: 18.112

10.  Physician empathy: definition, outcome-relevance and its measurement in patient care and medical education.

Authors:  Melanie Neumann; Christian Scheffer; Diethard Tauschel; Gabriele Lutz; Markus Wirtz; Friedrich Edelhäuser
Journal:  GMS Z Med Ausbild       Date:  2012-02-15
View more
  4 in total

1.  Systems pharmacogenomics - gene, disease, drug and placebo interactions: a case study in COMT.

Authors:  Kathryn T Hall; Joseph Loscalzo; Ted J Kaptchuk
Journal:  Pharmacogenomics       Date:  2019-05       Impact factor: 2.533

2.  Revisiting the Randomized Controlled Trial.

Authors:  Hassam Zulfiqar
Journal:  Pak J Med Sci       Date:  2017 May-Jun       Impact factor: 1.088

3.  On model-based time trend adjustments in platform trials with non-concurrent controls.

Authors:  Marta Bofill Roig; Pavla Krotka; Carl-Fredrik Burman; Ekkehard Glimm; Stefan M Gold; Katharina Hees; Peter Jacko; Franz Koenig; Dominic Magirr; Peter Mesenbrink; Kert Viele; Martin Posch
Journal:  BMC Med Res Methodol       Date:  2022-08-15       Impact factor: 4.612

Review 4.  How do they add up? The interaction between the placebo and treatment effect: A systematic review.

Authors:  Rémy Boussageon; Jeremy Howick; Raphael Baron; Florian Naudet; Bruno Falissard; Ghina Harika-Germaneau; Issa Wassouf; François Gueyffier; Nemat Jaafari; Clara Blanchard
Journal:  Br J Clin Pharmacol       Date:  2022-05-02       Impact factor: 3.716

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.